BioMarin Pharmaceutical (BMRN) Stock: Headed Up On FDA Approval

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced the approval of one of its treatment candidates. Of course, this led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about: The drug approval; what … Read more

BioMarin Pharmaceutical (BMRN) Stock: Here’s Why It’s Spiking

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) BioMarin Pharmaceutical wasn’t having the best of days in the market early on today. At the opening bell, the stock spiked up slightly before going on a steady downtrend. Just before 11:00, the stock broke below the breakeven point and continued falling throughout most of the morning. However, minutes ago, … Read more

Biotech Stock News (PFE) (AGN) (BMRN) (SRPT)

Pfizer (NYSE:PFE) & Allergan (NASDAQ:AGN) On November 23, 2015 big pharma giant Pfizer announced that it had set a deal to merge with another pharmaceutical company known as Allergan. The deal totals about $160 billion, and ends up being $363 per Allergan Share. The combined company is expected to keep the Pfizer tickers symbol “PFE” … Read more

BioMarin Pharmaceutical, Inc. (BMRN) signs an Agreement with Merck Serono: Wedbush Raises Price Target

Recently, BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN) signed an agreement with Merck Serono for purchasing rights to medications Kuvan and pegvaliase. This week, analyst Liana Moussatos from Wedbush weighed in on the biopharmaceutical company, maintaining a Neutral rating on the stock while raising her price target to $137 (from $131). Moussatos said, “BioMarin has bought the ex-US/Canada … Read more

Biotech Stocks Presenting Opportunity | Synergy Pharmaceuticals Inc (SGYP) | MannKind Corporation (MNKD) | Gilead Sciences (GILD) | BioMarin Pharmaceutical (BMRN)

Looking into the biotech market today, we’re seeing a sea of red. However, every time we have a bad day, we start to see great opportunities; and that’s no different today. I’ve dug up a few stocks in biotech that I believe to be great opportunities. Here they are… Synergy Pharmaceuticals Is Pulling Back, But … Read more

Biotech Stocks For The Opportunist | Synergy Pharmaceuticals (SGYP) | MannKind Corporation (MNKD) | BioMarin Pharmaceutical (BMRN) | ZIOPHARM Oncology (ZIOP)

The biotech market is having a great day today. If you check out the heat map on StockTwits, you can see that most stocks in healthcare are having a great day. While some may fall back down in short order, others are likely to continue climbing. With that said, here are 4 stocks in biotech … Read more

BioMarin (BMRN) Pharmaceutical Stock Climbs On Positive Study Data

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) BioMarin Pharmaceutical stock is up today after releasing positive results with regard to the Phase 2 proof-of-concept and dose funding study of BMN 111, also known as vosoritide. Today, we’ll take a look at the results to see what investors are so excited about, talk about what we’ve seen in … Read more

BioTech Stocks Are Starting To Recover | OREX | MNKD | ICPT

US stocks have had an incredibly rough time in the market this week. Mid last week, the Federal Reserve made a statement that they would not be aggressive in increasing interest rates. While the lack of aggression made investors happy short term, it seems as though reality set in early this week as the Dow … Read more